Advanced search
Publication Cover
Future Oncology Volume 5, 2009 - Issue 9
Submit an article Journal homepage
107
Views
0
CrossRef citations to date
0
Altmetric
Review

Fetal Cell Microchimerism in Cancer: A Meaningful Event?

Kiarash Khosrotehrania AP-HP, Hôpital Tenon, Department of Dermatology, 4 rue de la Chine, 75020Paris, France. [email protected]Correspondence[email protected]
View further author information
&
Selim Aractingib Université Pierre et Marie Curie, Paris, FranceView further author information
Pages 1441-1448 | Published online: 10 Nov 2009

Bibliography

  • Reed W , HannisdalE, SkovlundE, ThoresenS, LillengP, NeslandJM: Pregnancy and breast cancer: a population-based study.Virchows Arch.443(1), 44–50 (2003).
  • Slingluff CL Jr , ReintgenDS, VollmerRT, SeiglerHF: Malignant melanoma arising during pregnancy. A study of 100 patients.Ann. Surg.211(5), 552–557 (1990).
  • Khosrotehrani K , BianchiDW: Multi-lineage potential of fetal cells in maternal tissue: a legacy in reverse.J. Cell Sci.118(Pt 8), 1559–1563 (2005).
  • Nguyen Huu S , DubernardG, AractingiS, KhosrotehraniK: Feto–maternal cell trafficking: a transfer of pregnancy associated progenitor cells.Stem Cell Rev.2(2), 111–116 (2006).
  • Ariga H , OhtoH, BuschMPet al.: Kinetics of fetal cellular and cell-free DNA in the maternal circulation during and after pregnancy: implications for noninvasive prenatal diagnosis.Transfusion41(12), 1524–1530 (2001).
  • Krabchi K , Gros-LouisF, YanJet al.: Quantification of all fetal nucleated cells in maternal blood between the 18th and 22nd weeks of pregnancy using molecular cytogenetic techniques.Clin. Genet.60(2), 145–150 (2001).
  • Holzgreve W , GhezziF, Di NaroE, GanshirtD, MaymonE, HahnS: Disturbed feto–maternal cell traffic in preeclampsia.Obstet. Gynecol.91(5 Pt 1), 669–672 (1998).
  • Bianchi DW , WilliamsJM, SullivanLM, HansonFW, KlingerKW, ShuberAP: PCR quantitation of fetal cells in maternal blood in normal and aneuploid pregnancies.Am. J. Hum. Genet.61(4), 822–829 (1997).
  • Bianchi DW , FarinaA, WeberWet al.: Significant fetal-maternal hemorrhage after termination of pregnancy: implications for development of fetal cell microchimerism.Am. J. Obstet. Gynecol.184(4), 703–706 (2001).
  • Khosrotehrani K , JohnsonKL, LauJ, DupuyA, ChaDH, BianchiDW: The influence of fetal loss on the presence of fetal cell microchimerism: a systematic review.Arthritis Rheum.48(11), 3237–3241 (2003).
  • Bonney EA , MatzingerP: The maternal immune system’s interaction with circulating fetal cells.J. Immunol.158(1), 40–47 (1997).
  • Khosrotehrani K , JohnsonKL, GueganS, StrohH, BianchiDW: Natural history of fetal cell microchimerism during and following murine pregnancy.J. Reprod. Immunol.66(1), 1–12 (2005).
  • Lambert NC , EvansPC, HashizumiTLet al.: Cutting edge: persistent fetal microchimerism in T lymphocytes is associated with HLA-DQA1*0501: implications in autoimmunity.J. Immunol.164(11), 5545–5548 (2000).
  • Artlett CM , O’HanlonTP, LopezAM, SongYW, MillerFW, RiderLG: HLA-DQA1 is not an apparent risk factor for microchimerism in patients with various autoimmune diseases and in healthy individuals.Arthritis Rheum.48(9), 2567–2572 (2003).
  • Bianchi DW : Fetal cells in the mother: from genetic diagnosis to diseases associated with fetal cell microchimerism.Eur. J. Obstet. Gynecol. Reprod. Biol.92(1), 103–108 (2000).
  • O’Donoghue K , ChoolaniM, ChanJet al.: Identification of fetal mesenchymal stem cells in maternal blood: implications for noninvasive prenatal diagnosis.Mol. Hum. Reprod.9(8), 497–502 (2003).
  • O’Donoghue K , ChanJ, De LaFJet al.: Microchimerism in female bone marrow and bone decades after fetal mesenchymal stem-cell trafficking in pregnancy.Lancet364(9429), 179–182 (2004).
  • Bianchi DW , ZickwolfGK, WeilGJ, SylvesterS, DeMariaMA: Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum.Proc. Natl Acad. Sci. USA93(2), 705–708 (1996).
  • Lambert NC , LoYM, EricksonTDet al.: Male microchimerism in healthy women and women with scleroderma: cells or circulating DNA? A quantitative answer.Blood100(8), 2845–2851 (2002).
  • Artlett CM , CoxLA, RamosRCet al.: Increased microchimeric CD4+ T lymphocytes in peripheral blood from women with systemic sclerosis.Clin. Immunol.103(3 Pt 1), 303–308 (2002).
  • Nelson JL : Maternal-fetal immunology and autoimmune disease: is some autoimmune disease auto-alloimmune or allo-autoimmune?Arthritis Rheum.39(2), 191–194 (1996).
  • Nelson JL , FurstDE, MaloneySet al.: Microchimerism and HLA-compatible relationships of pregnancy in scleroderma.Lancet351(9102), 559–562 (1998).
  • Artlett CM , SmithJB, JimenezSA: Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis.N. Engl. J. Med.338(17), 1186–1191 (1998).
  • Gannage M , AmouraZ, LantzO, PietteJC, Caillat-ZucmanS: Feto–maternal microchimerism in connective tissue diseases.Eur. J. Immunol.32(12), 3405–3413 (2002).
  • Scaletti C , VultaggioA, BonifacioSet al.: Th2-oriented profile of male offspring T cells present in women with systemic sclerosis and reactive with maternal major histocompatibility complex antigens.Arthritis Rheum.46(2), 445–450 (2002).
  • Khosrotehrani K , BianchiDW: Fetal cell microchimerism: helpful or harmful to the parous woman?Curr. Opin. Obstet. Gynecol.15(2), 195–199 (2003).
  • Khosrotehrani K , LeducM, BachyVet al.: Pregnancy allows the transfer and differentiation of fetal lymphoid progenitors into functional T and B cells in mothers.J. Immunol.180(2), 889–897 (2008).
  • Mold JE , MichaelssonJ, BurtTDet al.: Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero.Science.322(5907), 1562–1565 (2008).
  • Matsuoka K , IchinoheT, HashimotoD, AsakuraS, TanimotoM, TeshimaT: Fetal tolerance to maternal antigens improves the outcome of allogeneic bone marrow transplantation by a CD4+ CD25+ T-cell-dependent mechanism.Blood.107(1), 404–409 (2006).
  • Burlingham WJ , GrailerAP, HeiseyDMet al.: The effect of tolerance to noninherited maternal HLA antigens on the survival of renal transplants from sibling donors.N. Engl. J. Med.339(23), 1657–1664 (1998).
  • van Rood JJ , LoberizaFRJr, ZhangMJet al.: Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling.Blood.99(5), 1572–1577 (2002).
  • Molitor-Dart ML , AndrassyJ, KwunJet al.: Developmental exposure to noninherited maternal antigens induces CD4+ T regulatory cells: relevance to mechanism of heart allograft tolerance.J. Immunol.179(10), 6749–6761 (2007).
  • Burlingham WJ : A lesson in tolerance – maternal instruction to fetal cells.N. Engl. J. Med.360(13), 1355–1357 (2009).
  • Khosrotehrani K , JohnsonKL, ChaDH, SalomonRN, BianchiDW: Transfer of fetal cells with multilineage potential to maternal tissue.JAMA292(1), 75–80 (2004).
  • Khosrotehrani K , ReyesRR, JohnsonKLet al.: Fetal cells participate over time in the response to specific types of murine maternal hepatic injury.Hum. Reprod.22(3), 654–661 (2007).
  • Wang Y , IwataniH, ItoTet al.: Fetal cells in mother rats contribute to the remodeling of liver and kidney after injury.Biochem. Biophys. Res. Commun.325(3), 961–967 (2004).
  • Tan XW , LiaoH, SunL, OkabeM, XiaoZC, DaweGS: Fetal microchimerism in the maternal mouse brain: a novel population of fetal progenitor or stem cells able to cross the blood-brain barrier?Stem Cells23(10), 1443–1452 (2005).
  • Nguyen Huu S , OsterM, UzanS, ChareyreF, AractingiS, KhosrotehraniK: Maternal neoangiogenesis during pregnancy partly derives from fetal endothelial progenitor cells.Proc. Natl Acad. Sci. USA104(6), 1871–1876 (2007).
  • Rosen JM , JordanCT: The increasing complexity of the cancer stem cell paradigm.Science324(5935), 1670–1673 (2009).
  • Aractingi S , KanitakisJ, EuvrardSet al.: Skin carcinoma arising from donor cells in a kidney transplant recipient.Cancer Res.65(5), 1755–1760 (2005).
  • Barozzi P , LuppiM, FacchettiFet al.: Post-transplant Kaposi sarcoma originates from the seeding of donor-derived progenitors.Nat. Med.9(5), 554–561 (2003).
  • Gadi VK , NelsonJL: Fetal microchimerism in women with breast cancer.Cancer Res.67(19), 9035–9038 (2007).
  • Gadi VK , MaloneKE, GuthrieKA, PorterPL, NelsonJL: Case–control study of fetal microchimerism and breast cancer.PLoS ONE3(3), E1706 (2008).
  • Gilmore GL , HaqB, ShadduckRK, JasthySL, ListerJ: Fetal–maternal microchimerism in normal parous females and parous female cancer patients.Exp. Hematol.36(9), 1073–1077 (2008).
  • Lambert NC , EricksonTD, YanZet al.: Quantification of maternal microchimerism by HLA-specific real-time polymerase chain reaction: studies of healthy women and women with scleroderma.Arthritis Rheum.50(3), 906–914 (2004).
  • Evans PC , LambertN, MaloneyS, FurstDE, MooreJM, NelsonJL: Long-term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with scleroderma.Blood93(6), 2033–2037 (1999).
  • Darrasse-Jeze G , BergotAS, DurgeauAet al.: Tumor emergence is sensed by self-specific CD44hi memory Tregs that create a dominant tolerogenic environment for tumors in mice.J. Clin. Invest.119(9), 2648–2662 (2009).
  • Pack GT , ScharnagelIM: The prognosis for malignant melanoma in the pregnant woman.Cancer4(2), 324–334 (1951).
  • Houghton AN , FlanneryJ, ViolaMV: Malignant melanoma of the skin occurring during pregnancy.Cancer48(2), 407–410 (1981).
  • Reintgen DS , McCartyKSJr, VollmerR, CoxE, SeiglerHF: Malignant melanoma and pregnancy.Cancer55(6), 1340–1344 (1985).
  • O’Meara AT , CressR, XingG, DanielsenB, SmithLH: Malignant melanoma in pregnancy. A population-based evaluation.Cancer.103(6), 1217–1226 (2005).
  • MacKie RM , BufalinoR, MorabitoA, SutherlandC, CascinelliN: Lack of effect of pregnancy on outcome of melanoma. For the World Health Organisation melanoma programme.Lancet337(8742), 653–655 (1991).
  • Travers RL , SoberAJ, BerwickM, MihmMCJr, BarnhillRL, DuncanLM: Increased thickness of pregnancy-associated melanoma.Br. J. Dermatol.132(6), 876–883 (1995).
  • Albrektsen G , HeuchI, KvaleG: The short-term and long-term effect of a pregnancy on breast cancer risk: a prospective study of 802,457 parous Norwegian women.Br. J. Cancer.72(2), 480–484 (1995).
  • Lambe M , HsiehC, TrichopoulosD, EkbomA, PaviaM, AdamiHO: Transient increase in the risk of breast cancer after giving birth.N. Engl. J. Med.331(1), 5–9 (1994).
  • Cha D , KhosrotehraniK, KimY, StrohH, BianchiDW, JohnsonKL: Cervical cancer and microchimerism.Obstet. Gynecol.102(4), 774–781 (2003).
  • O’Donoghue K , SultanHA, Al AllafFA, AndersonJR, Wyatt-AshmeadJ, FiskNM: Microchimeric fetal cells cluster at sites of tissue injury in lung decades after pregnancy.Reprod. Biomed. Online.16(3), 382–390 (2008).
  • Cirello V , RecalcatiMP, MuzzaMet al.: Fetal cell microchimerism in papillary thyroid cancer: a possible role in tumor damage and tissue repair.Cancer Res.68(20), 8482–8488 (2008).
  • Dubernard G , OsterM, ChareyreFet al.: Increased fetal cell microchimerism in high grade breast carcinomas occurring during pregnancy.Int. J. Cancer.124(5), 1054–1059 (2009).
  • Nguyen Huu S , KhosrotehraniK, OsterM, MogueletP, EspieMJ, AractingiS: Early phase of maternal skin carcinogenesis recruits long-term engrafted fetal cells.Int. J. Cancer.123(11), 2512–2517 (2008).
  • Dubernard G , AractingiS, OsterMet al.: Breast cancer stroma frequently recruits fetal derived cells during pregnancy.Breast Cancer Res.10(1), R14 (2008).
  • Nguyen Huu S , OsterM, AvrilMFet al.: Fetal microchimeric cells participate in tumor angiogenesis in melanomas occurring during pregnancy.Am. J. Pathol.174(2), 630–637 (2009).
  • Sawicki JA : Fetal microchimerism and cancer.Cancer Res.68(23), 9567–9569 (2008).
  • Galiano RD , TepperOM, PeloCRet al.: Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells.Am. J. Pathol.164(6), 1935–1947 (2004).
  • Studeny M , MariniFC, ChamplinRE, ZompettaC, FidlerIJ, AndreeffM: Bone marrow-derived mesenchymal stem cells as vehicles for interferon-β delivery into tumors.Cancer Res.62(13), 3603–3608 (2002).
  • Karnoub AE , DashAB, VoAPet al.: Mesenchymal stem cells within tumor stroma promote breast cancer metastasis.Nature.449(7162), 557–563 (2007).
  • Dadras SS , Lange-AsschenfeldtB, VelascoPet al.: Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes.Mod. Pathol.18(9), 1232–1242 (2005).
  • Dadras SS , PaulT, BertonciniJet al.: Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival.Am. J. Pathol.162(6), 1951–1960 (2003).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.